E1	Age:T1 Eq-Comparison:E2
E2	Eq-Comparison:T2 Value:T80 Operator:T81 Value:T82 Temporal-Unit:T83
E3	Condition:T3 Name:T84
E4	Observation:T4 Name:T133
E5	Age:T5 Eq-Comparison:E6
E6	Eq-Comparison:T6 Operator:T85 Value:T86 Temporal-Unit:T87
E7	Age:T7 Eq-Comparison:E8
E8	Eq-Comparison:T8 Operator:T88 Value:T89 Temporal-Unit:T90
E9	Modifier:T9 Modifies:T91
E10	Condition:T10 Name:T91
E11	Condition:T11 Name:T92
E12	Allergy:T12 Name:T134
E13	Other:T13 Is-Other:E14
E14	Condition:T14 Name:T93
E15	Modifier:T15 Modifies:T94
E16	Condition:T16 Name:T94 Acuteness:T74
E17	Condition:T17 Name:T95
E18	Eq-Comparison:T18 Temporal-Period:T96
E19	Condition:T19 Name:T97 Temporality:E18
E20	Condition:T20 Name:T98
E21	Condition:T21 Name:T99
E23	Condition:T23 Name:T100 Acuteness:T22
E24	Condition:T24 Name:T101
E25	Condition:T25 Name:T102
E26	Condition:T26 Name:T103
E27	Condition:T27 Name:T104
E29	Condition:T29 Name:T105 Acuteness:T28
E30	Condition:T30 Name:T106
E31	Modifier:T31 Modifies:T106
E32	Or:T32 Arg:E31 Arg2:E33
E34	Drug:T34 Name:T108
E35	Or:T35 Arg:E80 Arg2:E39
E36	Modifier:T36 Modifies:T109
E37	Or:T37 Arg:E36 Arg2:E38
E38	Modifier:T38 Modifies:T109
E39	Drug:T39 Name:T109
E40	Temporal-Connection:T40 Arg:E39 Arg2:E41
E41	Eq-Comparison:T41 Value:T110 Temporal-Unit:T111
E42	Temporal-Connection:T42 Arg:E41 Arg2:E43
E43	Study:T43 
E44	Procedure:T44 Temporality:E49
E45	Drug:T45 Name:T112
E46	Drug:T46 Name:T113
E47	Or:T47 Arg:E46 Arg2:E48
E48	Drug:T48 Name:T114
E49	Eq-Comparison:T49 Value:T115 Temporal-Unit:T116
E50	Temporal-Connection:T50 Arg:E49 Arg2:E51
E51	Study:T51 
E52	Drug:T52 Name:T118 Temporality:E58
E53	Or:T53 Arg:E52 Arg2:E55
E55	Drug:T55 Name:T119 Temporality:E58
E56	Or:T56 Arg:E55 Arg2:E57
E57	Procedure:T57 Name:T120 Temporality:E58
E58	Eq-Comparison:T58 Temporal-Period:T121 Value:T122 Temporal-Unit:T123
E59	Drug:T59 Name:T125
E60	Or:T60 Arg:E59 Arg2:E61
E61	Drug:T61 
E62	Temporal-Connection:T62 Arg:E61 Arg2:E63
E63	Eq-Comparison:T63 Value:T127 Temporal-Unit:T128
E64	Temporal-Connection:T64 Arg:E63 Arg2:E65
E65	Study:T65 
E66	Other:T66 Is-Other:E67
E67	Study:T67 Study-Of:E70
E68	Study:T68 Study-Of:E70
E69	Or:T69 Arg:E68 Arg2:E82
E70	Drug:T70 Temporality:E72
E71	Or:T71 Arg:E83 Arg2:E72
E72	Eq-Comparison:T72 Operator:T129 Value:T130 Temporal-Unit:T131
E73	Temporal-Connection:T73 Arg:E72 Arg2:E75
E75	Study:T75 
E76	Condition:T76 Name:T132
E77	Study:T77 Study-Of:E78
E78	Drug:T78 
E33	Modifier:T33 Modifies:T106
E79	Or:T107 Arg:E34 Arg2:E80
E80	Drug:T135 Name:T136
E54	Modifier:T54 Modifies:T125
E81	Condition:T117 Name:T124
E82	Modifier:T126 Modifies:E70
E83	Modifier:T137 Modifies:E70
T1	Age 34 38	aged
T2	Eq-Comparison 39 50	6-36 months
T3	Condition 69 86	Atopic Dermatitis
T4	Observation 100 112	SCORAD index
T5	Age 137 140	Age
T6	Eq-Comparison 141 151	< 6 months
T7	Age 157 160	age
T8	Eq-Comparison 161 172	> 36 months
T9	Modifier 179 183	skin
T10	Condition 184 194	infections
T11	Condition 201 211	ichthyosis
T12	Allergy 223 232	allergies
T13	Other 239 244	other
T14	Condition 245 262	allergic diseases
T15	Modifier 277 285	systemic
T16	Condition 286 294	diseases
T17	Condition 301 327	congenital cardiac defects
T18	Eq-Comparison 334 340	active
T19	Condition 341 353	tuberculosis
T20	Condition 360 379	autoimmune diseases
T21	Condition 386 402	immunodeficiency
T22	Acuteness 409 416	chronic
T23	Condition 417 444	inflammatory bowel diseases
T24	Condition 451 465	celiac disease
T25	Condition 472 487	cystic fibrosis
T26	Condition 494 512	metabolic diseases
T27	Condition 519 529	malignancy
T28	Acuteness 536 543	chronic
T29	Condition 544 562	pulmonary diseases
T30	Condition 569 582	malformations
T31	Modifier 590 606	gastrointestinal
T32	Or 607 613	and/or
T34	Drug 656 666	prebiotics
T35	Or 678 679	/
T36	Modifier 679 688	symbiotic
T37	Or 688 689	/
T38	Modifier 689 697	systemic
T39	Drug 698 714	immunomodulators
T40	Temporal-Connection 715 721	during
T41	Eq-Comparison 726 733	4 weeks
T42	Temporal-Connection 734 740	before
T43	Study 741 750	enrolment
T44	Procedure 757 767	treatments
T45	Drug 773 797	topical immunomodulators
T46	Drug 799 809	Tacrolimus
T47	Or 810 812	or
T48	Drug 813 825	Pimecrolimus
T49	Eq-Comparison 827 848	over the three months
T50	Temporal-Connection 849 857	prior to
T51	Study 858 867	enrolment
T52	Drug 881 896	corticosteroids
T53	Or 897 899	or
T55	Drug 900 923	calcineurin antagonists
T56	Or 924 926	or
T57	Procedure 927 939	phototherapy
T58	Eq-Comparison 947 963	previous 4 weeks
T59	Drug 986 997	antibiotics
T60	Or 998 1000	or
T61	Drug 1014 1019	drugs
T62	Temporal-Connection 1020 1026	during
T63	Eq-Comparison 1027 1034	4 weeks
T64	Temporal-Connection 1035 1041	before
T65	Study 1042 1047	study
T66	Other 1203 1208	other
T67	Study 1209 1216	studies
T68	Study 1227 1242	investigational
T69	Or 1243 1245	or
T70	Drug 1255 1263	products
T71	Or 1278 1280	or
T72	Eq-Comparison 1281 1297	within two weeks
T73	Temporal-Connection 1298 1306	prior to
T75	Study 1322 1327	study
T76	Condition 1334 1350	hypersensitivity
T77	Study 1378 1383	study
T78	Drug 1384 1391	product
T79	Life-Stage-And-Gender 25 33	Children
T80	Eq-Value 39 40	6
T81	Eq-Operator 40 41	-
T82	Eq-Value 41 43	36
T83	Eq-Temporal-Unit 44 50	months
T84	Condition-Name 69 86	Atopic Dermatitis
T85	Eq-Operator 141 142	<
T86	Eq-Value 143 144	6
T87	Eq-Temporal-Unit 145 151	months
T88	Eq-Operator 161 162	>
T89	Eq-Value 163 165	36
T90	Eq-Temporal-Unit 166 172	months
T91	Condition-Name 184 194	infections
T92	Condition-Name 201 211	ichthyosis
T93	Condition-Name 245 262	allergic diseases
T94	Condition-Name 286 294	diseases
T95	Condition-Name 301 327	congenital cardiac defects
T96	Eq-Temporal-Period 334 340	active
T97	Condition-Name 341 353	tuberculosis
T98	Condition-Name 360 379	autoimmune diseases
T99	Condition-Name 386 402	immunodeficiency
T100	Condition-Name 417 444	inflammatory bowel diseases
T101	Condition-Name 451 465	celiac disease
T102	Condition-Name 472 487	cystic fibrosis
T103	Condition-Name 494 512	metabolic diseases
T104	Condition-Name 519 529	malignancy
T105	Condition-Name 544 562	pulmonary diseases
T106	Condition-Name 569 582	malformations
T108	Drug-Name 656 666	prebiotics
T109	Drug-Name 698 714	immunomodulators
T110	Eq-Value 726 727	4
T111	Eq-Temporal-Unit 728 733	weeks
T112	Drug-Name 773 797	topical immunomodulators
T113	Drug-Name 799 809	Tacrolimus
T114	Drug-Name 813 825	Pimecrolimus
T115	Eq-Value 836 841	three
T116	Eq-Temporal-Unit 842 848	months
T118	Drug-Name 881 896	corticosteroids
T119	Drug-Name 900 923	calcineurin antagonists
T120	Procedure-Name 927 939	phototherapy
T121	Eq-Temporal-Period 947 955	previous
T122	Eq-Value 956 957	4
T123	Eq-Temporal-Unit 958 963	weeks
T125	Drug-Name 986 997	antibiotics
T127	Eq-Value 1027 1028	4
T128	Eq-Temporal-Unit 1029 1034	weeks
T129	Eq-Operator 1281 1287	within
T130	Eq-Value 1288 1291	two
T131	Eq-Temporal-Unit 1292 1297	weeks
T132	Condition-Name 1334 1350	hypersensitivity
T133	Observation-Name 100 112	SCORAD index
T134	Allergy-Name 218 222	food
T33	Modifier 614 631	respiratory tract
T107	Or 666 667	/
T135	Drug 668 678	probiotics
T136	Drug-Name 668 678	probiotics
T54	Modifier 977 985	systemic
T117	Condition 1006 1013	mycotic
T124	Condition-Name 1006 1013	mycotic
T126	Modifier 1246 1254	marketed
T137	Modifier 1264 1277	concomitantly
T74	Acuteness 269 276	chronic
A1	Temporal-Connection-Type-Value E40 during
A2	Temporal-Connection-Type-Value E42 before
A3	Temporal-Connection-Type-Value E50 before
A4	Temporal-Connection-Type-Value E62 during
A5	Temporal-Connection-Type-Value E64 before
A6	Temporal-Connection-Type-Value E73 before
A7	Life-Stage-And-Gender-Type T79 child
A8	Eq-Operator-Value T81 BETWEEN
A9	Eq-Temporal-Unit-Value T83 month
A10	Eq-Operator-Value T85 LT
A11	Eq-Temporal-Unit-Value T87 month
A12	Eq-Operator-Value T88 GT
A13	Eq-Temporal-Unit-Value T90 month
A14	Eq-Temporal-Period-Value T96 present
A15	Eq-Temporal-Unit-Value T111 week
A16	Eq-Temporal-Unit-Value T116 month
A18	Eq-Temporal-Period-Value T121 past
A19	Eq-Temporal-Unit-Value T123 week
A21	Eq-Temporal-Unit-Value T128 week
A22	Eq-Operator-Value T129 LTEQ
A23	Eq-Temporal-Unit-Value T131 week
A24	Observation-Type-Value T133 clinical-score
A25	Acuteness-Type-Value T22 chronic
A26	Acuteness-Type-Value T28 chronic
A27	Acuteness-Type-Value T74 chronic
R1	Found-By Arg1:E3 Arg2:E4
R2	Using Arg1:E44 Arg2:E45
R3	Example-Of Arg1:E46 Arg2:E45
R4	Example-Of Arg1:E48 Arg2:E45
R5	Treatment-For Arg1:E61 Arg2:E81
R6	Caused-By Arg1:E76 Arg2:E78
